These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. Aime S; Barge A; Cabella C; Crich SG; Gianolio E Curr Pharm Biotechnol; 2004 Dec; 5(6):509-18. PubMed ID: 15579040 [TBL] [Abstract][Full Text] [Related]
6. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. Ho C; Hitchens TK Curr Pharm Biotechnol; 2004 Dec; 5(6):551-66. PubMed ID: 15579044 [TBL] [Abstract][Full Text] [Related]
10. Iron oxide MR contrast agents for molecular and cellular imaging. Bulte JW; Kraitchman DL NMR Biomed; 2004 Nov; 17(7):484-99. PubMed ID: 15526347 [TBL] [Abstract][Full Text] [Related]
11. MR techniques for in vivo molecular and cellular imaging. Delikatny EJ; Poptani H Radiol Clin North Am; 2005 Jan; 43(1):205-20. PubMed ID: 15693657 [TBL] [Abstract][Full Text] [Related]
12. Targeted contrast agents for magnetic resonance imaging and ultrasound. Morawski AM; Lanza GA; Wickline SA Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020 [TBL] [Abstract][Full Text] [Related]
13. [Possible target specific molecular imaging with ultrasound contrast agents]. Mäurer M; Linker R; Reinhardt M; Hauff P Radiologe; 2005 Jun; 45(6):560-8. PubMed ID: 15912322 [TBL] [Abstract][Full Text] [Related]
17. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents. Patel D; Kell A; Simard B; Xiang B; Lin HY; Tian G Biomaterials; 2011 Feb; 32(4):1167-76. PubMed ID: 21035183 [TBL] [Abstract][Full Text] [Related]
18. Medical application of functionalized magnetic nanoparticles. Ito A; Shinkai M; Honda H; Kobayashi T J Biosci Bioeng; 2005 Jul; 100(1):1-11. PubMed ID: 16233845 [TBL] [Abstract][Full Text] [Related]